{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:08:28Z","timestamp":1791976108486,"version":"4.4.0"},"reference-count":218,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07260-1","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:50:10Z","timestamp":1763463010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["HMMR in human cancers: regulatory mechanism and biological function"],"prefix":"10.1186","volume":"23","author":[{"given":"Yanghao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihuang","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhisen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8728-6819","authenticated-orcid":false,"given":"Chongchang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"7260_CR1","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/molecules29030739","volume":"29","author":"K Valachov\u00e1","year":"2024","unstructured":"Valachov\u00e1 K, Hassan ME, \u0160olt\u00e9s L. Hyaluronan: sources, structure, features and applications. Molecules. 2024;29:739. https:\/\/doi.org\/10.3390\/molecules29030739.","journal-title":"Molecules"},{"key":"7260_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1046\/j.1365-2796.1997.00170.x","volume":"242","author":"JR Fraser","year":"1997","unstructured":"Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997;242:27\u201333. https:\/\/doi.org\/10.1046\/j.1365-2796.1997.00170.x.","journal-title":"J Intern Med"},{"key":"7260_CR3","doi-asserted-by":"publisher","first-page":"100495","DOI":"10.1016\/j.mtbio.2022.100495","volume":"17","author":"M Wang","year":"2022","unstructured":"Wang M, Deng Z, Guo Y, Xu P. Designing functional hyaluronic acid-based hydrogels for cartilage tissue engineering. Mater Today Bio. 2022;17:100495. https:\/\/doi.org\/10.1016\/j.mtbio.2022.100495.","journal-title":"Mater Today Bio"},{"key":"7260_CR4","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1111\/j.1349-7006.2008.00885.x","volume":"99","author":"N Itano","year":"2008","unstructured":"Itano N, Zhuo L, Kimata K. Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression. Cancer Sci. 2008;99:1720\u201325. https:\/\/doi.org\/10.1111\/j.1349-7006.2008.00885.x.","journal-title":"Cancer Sci"},{"key":"7260_CR5","doi-asserted-by":"publisher","first-page":"10296","DOI":"10.3390\/ijms241210296","volume":"24","author":"GN Iaconisi","year":"2023","unstructured":"Iaconisi GN, Lunetti P, Gallo N, Cappello AR, Fiermonte G, Dolce V, et al. Hyaluronic acid: a powerful biomolecule with wide-ranging applications-a comprehensive review. Int J Mol Sci. 2023;24:10296. https:\/\/doi.org\/10.3390\/ijms241210296.","journal-title":"Int J Mol Sci"},{"key":"7260_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2019.02.002","volume":"78\u201379","author":"S Garantziotis","year":"2019","unstructured":"Garantziotis S, Savani RC. Hyaluronan biology: a complex balancing act of structure, function, location and context. Matrix Biol: J Int Soc For Matrix Biol. 2019;78\u201379:1\u201310. https:\/\/doi.org\/10.1016\/j.matbio.2019.02.002.","journal-title":"Matrix Biol: J Int Soc For Matrix Biol"},{"key":"7260_CR7","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3390\/biom11081234","volume":"11","author":"A Kaul","year":"2021","unstructured":"Kaul A, Short WD, Keswani SG, Wang X. Immunologic roles of hyaluronan in dermal wound healing. Biomolecules. 2021;11:1234. https:\/\/doi.org\/10.3390\/biom11081234.","journal-title":"Biomolecules"},{"key":"7260_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/10428199909169610","volume":"35","author":"S Ilangumaran","year":"1999","unstructured":"Ilangumaran S, Borisch B, Hoessli DC. Signal transduction via CD44: role of plasma membrane microdomains. Leukemia Lymphoma. 1999;35:455\u201369. https:\/\/doi.org\/10.1080\/10428199909169610.","journal-title":"Leukemia Lymphoma"},{"key":"7260_CR9","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1089\/ten.TEA.2011.0371","volume":"18","author":"H Domev","year":"2012","unstructured":"Domev H, Amit M, Laevsky I, Dar A, Itskovitz-Eldor J. Efficient engineering of vascularized ectopic bone from human embryonic stem cell-derived mesenchymal stem cells. Tissue Eng Part A. 2012;18:2290\u2013302. https:\/\/doi.org\/10.1089\/ten.TEA.2011.0371.","journal-title":"Tissue Eng Part A"},{"key":"7260_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1126\/science.271.5248.509","volume":"271","author":"GF Weber","year":"1996","unstructured":"Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor-ligand interaction between CD44 and osteopontin (eta-1). Science. 1996;271:509\u201312. https:\/\/doi.org\/10.1126\/science.271.5248.509.","journal-title":"Science"},{"key":"7260_CR11","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3390\/biom11121850","volume":"11","author":"MH Mesrati","year":"2021","unstructured":"Mesrati MH, Syafruddin SE, Mohtar MA, Syahir A. CD44: a multifunctional mediator of cancer progression. Biomolecules. 2021;11:1850. https:\/\/doi.org\/10.3390\/biom11121850.","journal-title":"Biomolecules"},{"key":"7260_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704\u201315. https:\/\/doi.org\/10.1016\/j.cell.2008.03.027.","journal-title":"Cell"},{"key":"7260_CR13","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1158\/1078-0432.CCR-15-3115","volume":"22","author":"S Zhao","year":"2016","unstructured":"Zhao S, Chen C, Chang K, Karnad A, Jagirdar J, Kumar AP, et al. CD44 expression level and isoform contributes to pancreatic cancer cell plasticity, invasiveness, and response to therapy. Clin Cancer Res: Off J Am Assoc For Cancer Res. 2016;22:5592\u2013604. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-3115.","journal-title":"Clin Cancer Res: Off J Am Assoc For Cancer Res"},{"key":"7260_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/10428199409049691","volume":"14","author":"LM Pilarski","year":"1994","unstructured":"Pilarski LM, Masellis-Smith A, Belch AR, Yang B, Savani RC, Turley EA. RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: a mediator in B cell malignancy? Leukemia Lymphoma. 1994;14:363\u201374. https:\/\/doi.org\/10.3109\/10428199409049691.","journal-title":"Leukemia Lymphoma"},{"key":"7260_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/path.6082","volume":"260","author":"SE Tarullo","year":"2023","unstructured":"Tarullo SE, He Y, Daughters C, Knutson TP, Henzler CM, Price MA, et al. Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients. J Pathol. 2023;260:289\u2013303. https:\/\/doi.org\/10.1002\/path.6082.","journal-title":"J Pathol"},{"key":"7260_CR16","doi-asserted-by":"publisher","first-page":"608842","DOI":"10.3389\/fonc.2021.608842","volume":"11","author":"T Lu","year":"2021","unstructured":"Lu T, Zheng Y, Gong X, Lv Q, Chen J, Tu Z, et al. High expression of hyaluronan-mediated motility receptor predicts adverse outcomes: a potential therapeutic target for head and neck squamous cell carcinoma. Front Oncol. 2021;11:608842. https:\/\/doi.org\/10.3389\/fonc.2021.608842.","journal-title":"Front Oncol"},{"key":"7260_CR17","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3390\/ijms26020744","volume":"26","author":"JC Ram\u00edrez-Chiquito","year":"2025","unstructured":"Ram\u00edrez-Chiquito JC, Villegas-Ru\u00edz V, Medina-Vera I, S\u00e1nchez-Cruz I, Fr\u00edas-Soria CL, Caballero Palacios MC, et al. Hyaluronan-mediated motility receptor (HMMR) overexpression is correlated with poor survival in patients with B-ALL. Int J Mol Sci. 2025;26:744. https:\/\/doi.org\/10.3390\/ijms26020744.","journal-title":"Int J Mol Sci"},{"key":"7260_CR18","doi-asserted-by":"publisher","first-page":"998598","DOI":"10.3389\/fsurg.2022.998598","volume":"9","author":"J Shang","year":"2022","unstructured":"Shang J, Zhang X, Hou G, Qi Y. HMMR potential as a diagnostic and prognostic biomarker of cancer-speculation based on a pan-cancer analysis. Front Surg. 2022;9:998598. https:\/\/doi.org\/10.3389\/fsurg.2022.998598.","journal-title":"Front Surg"},{"key":"7260_CR19","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/0006-291X(82)92101-5","volume":"108","author":"EA Turley","year":"1982","unstructured":"Turley EA. Purification of a hyaluronate-binding protein fraction that modifies cell social behavior. Biochem Biophys Res Commun. 1982;108:1016\u201324. https:\/\/doi.org\/10.1016\/0006-291X(82)92101-5.","journal-title":"Biochem Biophys Res Commun"},{"key":"7260_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0014-4827(85)90486-0","volume":"161","author":"EA Turley","year":"1985","unstructured":"Turley EA, Torrance J. Localization of hyaluronate and hyaluronate-binding protein on motile and non-motile fibroblasts. Exp Cell Res. 1985;161:17\u201328. https:\/\/doi.org\/10.1016\/0014-4827(85)90486-0.","journal-title":"Exp Cell Res"},{"key":"7260_CR21","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1083\/jcb.117.6.1343","volume":"117","author":"C Hardwick","year":"1992","unstructured":"Hardwick C, Hoare K, Owens R, Hohn HP, Hook M, Moore D, et al. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol. 1992;117:1343\u201350. https:\/\/doi.org\/10.1083\/jcb.117.6.1343.","journal-title":"J Cell Biol"},{"key":"7260_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0092-8674(95)90048-9","volume":"82","author":"CL Hall","year":"1995","unstructured":"Hall CL, Yang B, Yang X, Zhang S, Turley M, Samuel S, et al. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell. 1995;82:19\u201326. https:\/\/doi.org\/10.1016\/0092-8674(95)90048-9.","journal-title":"Cell"},{"key":"7260_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/geno.1995.0022","volume":"30","author":"AP Spicer","year":"1995","unstructured":"Spicer AP, Roller ML, Camper SA, McPherson JD, Wasmuth JJ, Hakim S, et al. The human and mouse receptors for hyaluronan-mediated motility, RHAMM, genes (HMMR) map to human chromosome 5q33.2\u2013qter and mouse chromosome 11. Genomics. 1995;30:115\u201317. https:\/\/doi.org\/10.1006\/geno.1995.0022.","journal-title":"Genomics"},{"key":"7260_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0378-1119(98)00566-6","volume":"226","author":"C Fieber","year":"1999","unstructured":"Fieber C, Plug R, Sleeman J, Dall P, Ponta H, Hofmann M. Characterisation of the murine gene encoding the intracellular hyaluronan receptor IHABP (RHAMM). Gene. 1999;226:41\u201350. https:\/\/doi.org\/10.1016\/S0378-1119(98)00566-6.","journal-title":"Gene"},{"issue":"Pt 22","key":"7260_CR25","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1242\/jcs.112.22.3943","volume":"112","author":"V Assmann","year":"1999","unstructured":"Assmann V, Jenkinson D, Marshall JF, Hart IR. The intracellular hyaluronan receptor RHAMM\/IHABP interacts with microtubules and actin filaments. J Cell Sci. 1999;112(Pt 22):3943\u201354. https:\/\/doi.org\/10.1242\/jcs.112.22.3943.","journal-title":"J Cell Sci"},{"key":"7260_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.gep.2009.12.003","volume":"10","author":"P Casini","year":"2010","unstructured":"Casini P, Nardi I, Ori M. RHAMM mRNA expression in proliferating and migrating cells of the developing central nervous system. Gene Expression Patterns: GEP. 2010;10:93\u201397. https:\/\/doi.org\/10.1016\/j.gep.2009.12.003.","journal-title":"Gene Expression Patterns: GEP"},{"key":"7260_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41420-023-01341-0","volume":"9","author":"K Guo","year":"2023","unstructured":"Guo K, Liu C, Shi J, Lai C, Gao Z, Luo J, et al. HMMR promotes prostate cancer proliferation and metastasis via AURKA\/mTORC2\/E2F1 positive feedback loop. Cell Death Discov. 2023;9:48. https:\/\/doi.org\/10.1038\/s41420-023-01341-0.","journal-title":"Cell Death Discov"},{"key":"7260_CR28","doi-asserted-by":"publisher","first-page":"8617","DOI":"10.1016\/S0021-9258(18)52919-7","volume":"268","author":"B Yang","year":"1993","unstructured":"Yang B, Zhang L, Turley EA. Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM. J Biol Chem. 1993;268:8617\u201323.","journal-title":"J Biol Chem"},{"key":"7260_CR29","unstructured":"Human Protein Atlas. Human protein atlas portal. n.d. http:\/\/www.proteinatlas.org. July 1, 2025, ."},{"key":"7260_CR30","unstructured":"UniProt. n.d. http:\/\/www.uniprot.org. July 1, 2025, ."},{"key":"7260_CR31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-2105-10-136","volume":"10","author":"E Jain","year":"2009","unstructured":"Jain E, Bairoch A, Duvaud S, Phan I, Redaschi N, Suzek BE, et al. Infrastructure for the life sciences: design and implementation of the UniProt website. BMC Bioinf. 2009;10:136. https:\/\/doi.org\/10.1186\/1471-2105-10-136.","journal-title":"BMC Bioinf"},{"key":"7260_CR32","doi-asserted-by":"publisher","first-page":"20941","DOI":"10.18632\/oncotarget.24939","volume":"9","author":"Y-T Chen","year":"2018","unstructured":"Chen Y-T, Chen Z, Du Y-CN. Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells. Oncotarget. 2018;9:20941\u201352. https:\/\/doi.org\/10.18632\/oncotarget.24939.","journal-title":"Oncotarget"},{"key":"7260_CR33","doi-asserted-by":"publisher","first-page":"103923","DOI":"10.1155\/2014\/103923","volume":"2014","author":"C Tolg","year":"2014","unstructured":"Tolg C, McCarthy JB, Yazdani A, Turley EA. Hyaluronan and RHAMM in wound repair and the \u201ccancerization\u201d of stromal tissues. Biomed Res Int. 2014;2014:103923. https:\/\/doi.org\/10.1155\/2014\/103923.","journal-title":"Biomed Res Int"},{"key":"7260_CR34","doi-asserted-by":"publisher","first-page":"16753","DOI":"10.1073\/pnas.1114022108","volume":"108","author":"Y-CN Du","year":"2011","unstructured":"Du Y-CN, Chou C-K, Klimstra DS, Varmus H. Receptor for hyaluronan-mediated motility isoform B promotes liver metastasis in a mouse model of multistep tumorigenesis and a tail vein assay for metastasis. Proc Natl Acad Sci USA. 2011;108:16753\u201358. https:\/\/doi.org\/10.1073\/pnas.1114022108.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7260_CR35","first-page":"2256","volume":"7","author":"V Villegas-Ru\u00edz","year":"2014","unstructured":"Villegas-Ru\u00edz V, Salcedo M, Zentella-Dehesa A, de Oca EVM, Rom\u00e1n-Basaure E, Mantilla-Morales A, et al. A case of cervical cancer expressed three mRNA variant of hyaluronan-mediated motility receptor. Int J Clin And Exp Pathol. 2014;7:2256\u201364.","journal-title":"Int J Clin And Exp Pathol"},{"key":"7260_CR36","doi-asserted-by":"publisher","first-page":"10313","DOI":"10.3390\/ijms221910313","volume":"22","author":"BJ Messam","year":"2021","unstructured":"Messam BJ, Tolg C, McCarthy JB, Nelson AC, Turley EA. RHAMM is a multifunctional protein that regulates cancer progression. Int J Mol Sci. 2021;22:10313. https:\/\/doi.org\/10.3390\/ijms221910313.","journal-title":"Int J Mol Sci"},{"key":"7260_CR37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcb.240560406","volume":"56","author":"B Yang","year":"1994","unstructured":"Yang B, Hall CL, Yang BL, Savani RC, Turley EA. Identification of a novel heparin binding domain in RHAMM and evidence that it modifies HA mediated locomotion of ras-transformed cells. J Cellular Biochem. 1994;56:455\u201368. https:\/\/doi.org\/10.1002\/jcb.240560406.","journal-title":"J Cellular Biochem"},{"key":"7260_CR38","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/j.1460-2075.1994.tb06261.x","volume":"13","author":"B Yang","year":"1994","unstructured":"Yang B, Yang BL, Savani RC, Turley EA. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. Embo J. 1994;13:286\u201396. https:\/\/doi.org\/10.1002\/j.1460-2075.1994.tb06261.x.","journal-title":"Embo J"},{"key":"7260_CR39","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10822-004-5433-8","volume":"18","author":"MR Ziebell","year":"2004","unstructured":"Ziebell MR, Prestwich GD. Interactions of peptide mimics of hyaluronic acid with the receptor for hyaluronan mediated motility (RHAMM). J Comput-Aided Mol Des. 2004;18:597\u2013614. https:\/\/doi.org\/10.1007\/s10822-004-5433-8.","journal-title":"J Comput-Aided Mol Des"},{"key":"7260_CR40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.actbio.2023.05.009","volume":"167","author":"KM Koss","year":"2023","unstructured":"Koss KM, Sereda TJ, Kumirov VK, Wertheim JA. A class of peptides designed to replicate and enhance the receptor for hyaluronic acid mediated motility binding domain. Acta Biomaterialia. 2023;167:293\u2013308. https:\/\/doi.org\/10.1016\/j.actbio.2023.05.009.","journal-title":"Acta Biomaterialia"},{"key":"7260_CR41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.matbio.2018.08.002","volume":"78\u201379","author":"Z Cui","year":"2019","unstructured":"Cui Z, Liao J, Cheong N, Longoria C, Cao G, DeLisser HM, et al. The receptor for hyaluronan-mediated motility (CD168) promotes inflammation and fibrosis after acute lung injury. Matrix Biol: J Int Soc For Matrix Biol. 2019;78\u201379:255\u201371. https:\/\/doi.org\/10.1016\/j.matbio.2018.08.002.","journal-title":"Matrix Biol: J Int Soc For Matrix Biol"},{"key":"7260_CR42","doi-asserted-by":"publisher","first-page":"37406","DOI":"10.1074\/jbc.M112.360982","volume":"287","author":"JP Foley","year":"2012","unstructured":"Foley JP, Lam D, Jiang H, Liao J, Cheong N, McDevitt TM, et al. Toll-like receptor 2 (TLR2), transforming growth factor-\u03b2, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein a-stimulated macrophage chemotaxis. J Biol Chem. 2012;287:37406\u201319. https:\/\/doi.org\/10.1074\/jbc.M112.360982.","journal-title":"J Biol Chem"},{"key":"7260_CR43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/mc.22930","volume":"58","author":"JM Song","year":"2019","unstructured":"Song JM, Im J, Nho RS, Han YH, Upadhyaya P, Kassie F. Hyaluronan-CD44\/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells. Mol Carcinog. 2019;58:321\u201333. https:\/\/doi.org\/10.1002\/mc.22930.","journal-title":"Mol Carcinog"},{"key":"7260_CR44","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1039\/c5ib00222b","volume":"7","author":"KVN Esguerra","year":"2015","unstructured":"Esguerra KVN, Tolg C, Akentieva N, Price M, Cho C-F, Lewis JD, et al. Identification, design and synthesis of tubulin-derived peptides as novel hyaluronan mimetic ligands for the receptor for hyaluronan-mediated motility (RHAMM\/HMMR). Intgr Biol: Quant Biosci From Nano To Macro. 2015;7:1547\u201360. https:\/\/doi.org\/10.1039\/c5ib00222b.","journal-title":"Intgr Biol: Quant Biosci From Nano To Macro"},{"key":"7260_CR45","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1091\/mbc.e02-07-0377","volume":"14","author":"CA Maxwell","year":"2003","unstructured":"Maxwell CA, Keats JJ, Crainie M, Sun X, Yen T, Shibuya E, et al. RHAMM is a centrosomal protein that interacts with dynein and maintains spindle Pole stability. Mol Biol Of The Cell. 2003;14:2262\u201376. https:\/\/doi.org\/10.1091\/mbc.e02-07-0377.","journal-title":"Mol Biol Of The Cell"},{"key":"7260_CR46","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1083\/jcb.143.3.673","volume":"143","author":"T Wittmann","year":"1998","unstructured":"Wittmann T, Boleti H, Antony C, Karsenti E, Vernos I. Localization of the kinesin-like protein Xklp2 to spindle poles requires a leucine zipper, a microtubule-associated protein, and dynein. J Cell Biol. 1998;143:673\u201385. https:\/\/doi.org\/10.1083\/jcb.143.3.673.","journal-title":"J Cell Biol"},{"key":"7260_CR47","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.4161\/cc.29270","volume":"13","author":"H Chen","year":"2014","unstructured":"Chen H, Mohan P, Jiang J, Nemirovsky O, He D, Fleisch MC, et al. Spatial regulation of aurora a activity during mitotic spindle assembly requires RHAMM to correctly localize TPX2. Cell Cycle. 2014;13:2248\u201361. https:\/\/doi.org\/10.4161\/cc.29270.","journal-title":"Cell Cycle"},{"key":"7260_CR48","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1091\/mbc.E17-08-0531","volume":"29","author":"H Chen","year":"2018","unstructured":"Chen H, Connell M, Mei L, Reid GSD, Maxwell CA. The nonmotor adaptor HMMR dampens Eg5-mediated forces to preserve the kinetics and integrity of chromosome segregation. Mol Biol Of The Cell. 2018;29:786\u201396. https:\/\/doi.org\/10.1091\/mbc.E17-08-0531.","journal-title":"Mol Biol Of The Cell"},{"key":"7260_CR49","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/cells9040819","volume":"9","author":"Z He","year":"2020","unstructured":"He Z, Mei L, Connell M, Maxwell CA. Hyaluronan mediated motility receptor (HMMR) encodes an evolutionarily conserved homeostasis, mitosis, and meiosis regulator rather than a hyaluronan receptor. Cells. 2020;9:819. https:\/\/doi.org\/10.3390\/cells9040819.","journal-title":"Cells"},{"key":"7260_CR50","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1083\/jcb.201202112","volume":"198","author":"AK Dunsch","year":"2012","unstructured":"Dunsch AK, Hammond D, Lloyd J, Schermelleh L, Gruneberg U, Barr FA. Dynein light chain 1 and a spindle-associated adaptor promote dynein asymmetry and spindle orientation. J Cell Biol. 2012;198:1039\u201354. https:\/\/doi.org\/10.1083\/jcb.201202112.","journal-title":"J Cell Biol"},{"key":"7260_CR51","doi-asserted-by":"publisher","first-page":"e47495","DOI":"10.15252\/embr.201847495","volume":"20","author":"LJ Fulcher","year":"2019","unstructured":"Fulcher LJ, He Z, Mei L, Macartney TJ, Wood NT, Prescott AR, et al. FAM83D directs protein kinase CK1\u03b1 to the mitotic spindle for proper spindle positioning. EMBO Rep. 2019;20:e47495. https:\/\/doi.org\/10.15252\/embr.201847495.","journal-title":"EMBO Rep"},{"key":"7260_CR52","doi-asserted-by":"publisher","first-page":"26461","DOI":"10.1074\/jbc.M110.121491","volume":"285","author":"C Tolg","year":"2010","unstructured":"Tolg C, Hamilton SR, Morningstar L, Zhang J, Zhang S, Esguerra KV, et al. RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1\/ERK1\/2 activity. J Biol Chem. 2010;285:26461\u201374. https:\/\/doi.org\/10.1074\/jbc.M110.121491.","journal-title":"J Biol Chem"},{"key":"7260_CR53","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.actbio.2022.05.013","volume":"146","author":"AM Carvalho","year":"2022","unstructured":"Carvalho AM, Soares da Costa D, Reis RL, Pashkuleva I. RHAMM expression tunes the response of breast cancer cell lines to hyaluronan. Acta Biomaterialia. 2022;146:187\u201396. https:\/\/doi.org\/10.1016\/j.actbio.2022.05.013.","journal-title":"Acta Biomaterialia"},{"key":"7260_CR54","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10059-012-2294-1","volume":"33","author":"D Park","year":"2012","unstructured":"Park D, Kim Y, Kim H, Kim K, Lee Y-S, Choe J, et al. Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGF\u03b2 receptor interaction via CD44-PKC\u03b4. Mol And Cells. 2012;33:563\u201374. https:\/\/doi.org\/10.1007\/s10059-012-2294-1.","journal-title":"Mol And Cells"},{"key":"7260_CR55","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s13238-011-1113-3","volume":"2","author":"Q Meng","year":"2011","unstructured":"Meng Q, Xia Y. C-jun, at the crossroad of the signaling network. Protein Cell. 2011;2:889\u201398. https:\/\/doi.org\/10.1007\/s13238-011-1113-3.","journal-title":"Protein Cell"},{"key":"7260_CR56","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/path.4400","volume":"234","author":"C Meier","year":"2014","unstructured":"Meier C, Spitschak A, Abshagen K, Gupta S, Mor JM, Wolkenhauer O, et al. Association of RHAMM with E2F1 promotes tumour cell extravasation by transcriptional up-regulation of fibronectin. J Pathol. 2014;234:351\u201364. https:\/\/doi.org\/10.1002\/path.4400.","journal-title":"J Pathol"},{"key":"7260_CR57","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1083\/jcb.123.3.749","volume":"123","author":"SK Samuel","year":"1993","unstructured":"Samuel SK, Hurta RA, Spearman MA, Wright JA, Turley EA, Greenberg AH. TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J Cell Biol. 1993;123:749\u201358. https:\/\/doi.org\/10.1083\/jcb.123.3.749.","journal-title":"J Cell Biol"},{"key":"7260_CR58","doi-asserted-by":"publisher","first-page":"15279","DOI":"10.1074\/jbc.271.25.15279","volume":"271","author":"FM Amara","year":"1996","unstructured":"Amara FM, Entwistle J, Kuschak TI, Turley EA, Wright JA. Transforming growth factor-beta1 stimulates multiple protein interactions at a unique cis-element in the 3\u2019-untranslated region of the hyaluronan receptor RHAMM mRNA. J Biol Chem. 1996;271:15279\u201384. https:\/\/doi.org\/10.1074\/jbc.271.25.15279.","journal-title":"J Biol Chem"},{"key":"7260_CR59","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1158\/1541-7786.MCR-19-0877","volume":"18","author":"S Ye","year":"2020","unstructured":"Ye S, Liu Y, Fuller AM, Katti R, Ciotti GE, Chor S, et al. TGF\u03b2 and hippo pathways cooperate to enhance sarcomagenesis and metastasis through the hyaluronan-mediated motility receptor (HMMR). Mol Cancer Res. 2020;18:560\u201373. https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-0877.","journal-title":"Mol Cancer Res"},{"key":"7260_CR60","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1158\/0008-5472.CAN-17-4052","volume":"78","author":"S Ye","year":"2018","unstructured":"Ye S, Lawlor MA, Rivera-Reyes A, Egolf S, Chor S, Pak K, et al. YAP1-mediated suppression of USP31 enhances NF\u03baB activity to promote sarcomagenesis. Cancer Res. 2018;78:2705\u201320. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-4052.","journal-title":"Cancer Res"},{"key":"7260_CR61","doi-asserted-by":"publisher","first-page":"E89","DOI":"10.1073\/pnas.1319190110","volume":"111","author":"Z Wang","year":"2014","unstructured":"Wang Z, Wu Y, Wang H, Zhang Y, Mei L, Fang X, et al. Interplay of mevalonate and hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility. Proc Natl Acad Sci USA. 2014;111:E89\u201398. https:\/\/doi.org\/10.1073\/pnas.1319190110.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7260_CR62","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/carcin\/bgm259","volume":"29","author":"S-L Lin","year":"2008","unstructured":"Lin S-L, Chang D, Chiang A, Ying S-Y. Androgen receptor regulates CD168 expression and signaling in prostate cancer. Carcinogenesis. 2008;29:282\u201390. https:\/\/doi.org\/10.1093\/carcin\/bgm259.","journal-title":"Carcinogenesis"},{"key":"7260_CR63","doi-asserted-by":"publisher","first-page":"667","DOI":"10.4062\/biomolther.2021.040","volume":"29","author":"Y Sun","year":"2021","unstructured":"Sun Y, Li Z, Song K. AR-mTOR-SRF axis regulates HMMR expression in human prostate cancer cells. Biomolecules Ther. 2021;29:667\u201377. https:\/\/doi.org\/10.4062\/biomolther.2021.040.","journal-title":"Biomolecules Ther"},{"key":"7260_CR64","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.4161\/cc.7.21.7014","volume":"7","author":"S Sohr","year":"2008","unstructured":"Sohr S, Engeland K. RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53. Cell Cycle. 2008;7:3448\u201360. https:\/\/doi.org\/10.4161\/cc.7.21.7014.","journal-title":"Cell Cycle"},{"key":"7260_CR65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.canlet.2021.05.011","volume":"514","author":"A Lin","year":"2021","unstructured":"Lin A, Feng J, Chen X, Wang D, Wong M, Zhang G, et al. High levels of truncated RHAMM cooperate with dysfunctional p53 to accelerate the progression of pancreatic cancer. Cancer Lett. 2021;514:79\u201389. https:\/\/doi.org\/10.1016\/j.canlet.2021.05.011.","journal-title":"Cancer Lett"},{"key":"7260_CR66","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1158\/0008-5472.CAN-16-1589","volume":"77","author":"C Thangavel","year":"2017","unstructured":"Thangavel C, Boopathi E, Liu Y, Haber A, Ertel A, Bhardwaj A, et al. RB loss promotes prostate cancer metastasis. Cancer Res. 2017;77:982\u201395. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1589.","journal-title":"Cancer Res"},{"key":"7260_CR67","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1038\/onc.2009.282","volume":"28","author":"AM Barsotti","year":"2009","unstructured":"Barsotti AM, Prives C. Pro-proliferative FoxM1 is a target of p53-mediated repression. Oncogene. 2009;28:4295\u2013305. https:\/\/doi.org\/10.1038\/onc.2009.282.","journal-title":"Oncogene"},{"key":"7260_CR68","doi-asserted-by":"publisher","first-page":"112860","DOI":"10.1016\/j.yexcr.2021.112860","volume":"408","author":"D Yang","year":"2021","unstructured":"Yang D, Ma Y, Zhao P, Ma J, He C. HMMR is a downstream target of FOXM1 in enhancing proliferation and partial epithelial-to-mesenchymal transition of bladder cancer cells. Exp Cell Res. 2021;408:112860. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112860.","journal-title":"Exp Cell Res"},{"key":"7260_CR69","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1002\/mc.23815","volume":"63","author":"A Savardekar","year":"2024","unstructured":"Savardekar A, Fernandes E, Padhye-Pendse A, Gupta T, Pol J, Phadke M, et al. Adipocytes promote endometrial cancer progression through activation of the SIRT1-HMMR signaling axis. Mol Carcinog. 2024;63:2363\u201381. https:\/\/doi.org\/10.1002\/mc.23815.","journal-title":"Mol Carcinog"},{"key":"7260_CR70","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.molcel.2010.02.038","volume":"38","author":"L Song","year":"2010","unstructured":"Song L, Rape M. Regulated degradation of spindle assembly factors by the anaphase-promoting complex. Mol Cell. 2010;38:369\u201382. https:\/\/doi.org\/10.1016\/j.molcel.2010.02.038.","journal-title":"Mol Cell"},{"key":"7260_CR71","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/ng.2007.2","volume":"39","author":"MA Pujana","year":"2007","unstructured":"Pujana MA, Han J-DJ, Starita LM, Stevens KN, Tewari M, Ahn JS, et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet. 2007;39:1338\u201349. https:\/\/doi.org\/10.1038\/ng.2007.2.","journal-title":"Nat Genet"},{"key":"7260_CR72","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12967-024-05988-w","volume":"23","author":"X Niu","year":"2025","unstructured":"Niu X, Lu D, Zhan W, Sun J, Li Y, Shi Y, et al. miR-9-5p\/HMMR regulates the tumorigenesis and progression of clear cell renal cell carcinoma through EMT and JAK1\/STAT1 signaling pathway. J Transl Med. 2025;23:36. https:\/\/doi.org\/10.1186\/s12967-024-05988-w.","journal-title":"J Transl Med"},{"key":"7260_CR73","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10863-024-10004-3","volume":"56","author":"Z Li","year":"2024","unstructured":"Li Z, Zhu T, Yao F, Shen X, Xu M, Fu L, et al. LINC00665 promotes glycolysis in lung adenocarcinoma cells via the let-7c-5p\/HMMR axis. J Bioenerg and Biomembr. 2024;56:181\u201391. https:\/\/doi.org\/10.1007\/s10863-024-10004-3.","journal-title":"J Bioenerg and Biomembr"},{"key":"7260_CR74","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.cell.2006.08.053","volume":"127","author":"V Joukov","year":"2006","unstructured":"Joukov V, Groen AC, Prokhorova T, Gerson R, White E, Rodriguez A, et al. The BRCA1\/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly. Cell. 2006;127:539\u201352. https:\/\/doi.org\/10.1016\/j.cell.2006.08.053.","journal-title":"Cell"},{"key":"7260_CR75","doi-asserted-by":"publisher","first-page":"e1001199","DOI":"10.1371\/journal.pbio.1001199","volume":"9","author":"CA Maxwell","year":"2011","unstructured":"Maxwell CA, Ben\u00edtez J, G\u00f3mez-Bald\u00f3 L, Osorio A, Bonifaci N, Fern\u00e1ndez-Ramires R, et al. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol. 2011;9:e1001199. https:\/\/doi.org\/10.1371\/journal.pbio.1001199.","journal-title":"PLoS Biol"},{"key":"7260_CR76","doi-asserted-by":"publisher","first-page":"106315","DOI":"10.1016\/j.compbiomed.2022.106315","volume":"152","author":"A Balasundaram","year":"2023","unstructured":"Balasundaram A, C GPD. In silico analysis revealed the potential circRNA-miRNA-mRNA regulative network of non-small cell lung cancer (NSCLC). Comput In Biol And Med. 2023;152:106315. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106315.","journal-title":"Comput In Biol And Med"},{"key":"7260_CR77","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/1759-7714.14809","volume":"14","author":"Y Peng","year":"2023","unstructured":"Peng Y, Cui J, Ma K, Zhong X. Hsa_circ_0005273 acts as a sponge of miR-509-3p to promote the malignant behaviors of breast cancer by regulating HMMR expression. Thorac Cancer. 2023;14:794\u2013804. https:\/\/doi.org\/10.1111\/1759-7714.14809.","journal-title":"Thorac Cancer"},{"key":"7260_CR78","doi-asserted-by":"publisher","first-page":"111811","DOI":"10.1016\/j.mrfmmm.2022.111811","volume":"826","author":"Q Wang","year":"2023","unstructured":"Wang Q, Wu G, Fu L, Li Z, Wu Y, Zhu T, et al. Tumor-promoting roles of HMMR in lung adenocarcinoma. Mutat Res. 2023;826:111811. https:\/\/doi.org\/10.1016\/j.mrfmmm.2022.111811.","journal-title":"Mutat Res"},{"key":"7260_CR79","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.3390\/ijms25084214","volume":"25","author":"E Farias","year":"2024","unstructured":"Farias E, Terrematte P, Stransky B. Machine learning gene signature to metastatic ccRCC based on ceRNA network. Int J Mol Sci. 2024;25:4214. https:\/\/doi.org\/10.3390\/ijms25084214.","journal-title":"Int J Mol Sci"},{"key":"7260_CR80","doi-asserted-by":"publisher","first-page":"110217","DOI":"10.1016\/j.biopha.2020.110217","volume":"129","author":"W Li","year":"2020","unstructured":"Li W, Pan T, Jiang W, Zhao H. HCG18\/miR-34a-5p\/HMMR axis accelerates the progression of lung adenocarcinoma. Biomed Pharmacother. 2020;129:110217. https:\/\/doi.org\/10.1016\/j.biopha.2020.110217.","journal-title":"Biomed Pharmacother"},{"key":"7260_CR81","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1056\/NEJMra1715715","volume":"382","author":"LQM Chow","year":"2020","unstructured":"Chow LQM. Head and neck cancer. N Engl J Med. 2020;382:60\u201372. https:\/\/doi.org\/10.1056\/NEJMra1715715.","journal-title":"N Engl J Med"},{"key":"7260_CR82","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pi\u00f1eros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941\u201353. https:\/\/doi.org\/10.1002\/ijc.31937.","journal-title":"Int J Cancer"},{"key":"7260_CR83","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1200\/JCO.21.02508","volume":"41","author":"KJ Harrington","year":"2023","unstructured":"Harrington KJ, Burtness B, Greil R, Souli\u00e8res D, Tahara M, de Castro G, et al. Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study. J Clin Oncol. 2023;41:790\u2013802. https:\/\/doi.org\/10.1200\/JCO.21.02508.","journal-title":"J Clin Oncol"},{"key":"7260_CR84","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/annonc\/mdz084","volume":"30","author":"D Hashim","year":"2019","unstructured":"Hashim D, Genden E, Posner M, Hashibe M, Boffetta P. Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden. Ann Of Oncol. 2019;30:744\u201356. https:\/\/doi.org\/10.1093\/annonc\/mdz084.","journal-title":"Ann Of Oncol"},{"key":"7260_CR85","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA: A Cancer J For Clinicians. 2024;74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA: A Cancer J For Clinicians"},{"key":"7260_CR86","first-page":"1001","volume":"32","author":"Y Yamano","year":"2008","unstructured":"Yamano Y, Uzawa K, Shinozuka K, Fushimi K, Ishigami T, Nomura H, et al. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma. Int J Oncol. 2008;32:1001\u201309.","journal-title":"Int J Oncol"},{"key":"7260_CR87","doi-asserted-by":"publisher","first-page":"107329","DOI":"10.1016\/j.oraloncology.2025.107329","volume":"165","author":"M Richter","year":"2025","unstructured":"Richter M, Doll C, Hofmann E, Reds A, Mrosk F, Neumann K, et al. The prevalence and prognostic value of CD168 in early-stage oral squamous cell carcinoma. Oral Oncol. 2025;165:107329. https:\/\/doi.org\/10.1016\/j.oraloncology.2025.107329.","journal-title":"Oral Oncol"},{"key":"7260_CR88","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1002\/stem.1418","volume":"31","author":"H Shigeishi","year":"2013","unstructured":"Shigeishi H, Biddle A, Gammon L, Emich H, Rodini CO, Gemenetzidis E, et al. Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3\u03b2 influenced by CD44 and RHAMM. STEM Cells. 2013;31:2073\u201383. https:\/\/doi.org\/10.1002\/stem.1418.","journal-title":"STEM Cells"},{"key":"7260_CR89","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s00432-014-1653-z","volume":"140","author":"H Shigeishi","year":"2014","unstructured":"Shigeishi H, Higashikawa K, Takechi M. Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers. J Cancer Res And Clin Oncol. 2014;140:1629\u201340. https:\/\/doi.org\/10.1007\/s00432-014-1653-z.","journal-title":"J Cancer Res And Clin Oncol"},{"key":"7260_CR90","first-page":"341","volume":"21","author":"H Shigeishi","year":"2009","unstructured":"Shigeishi H, Ohta K, Hiraoka M, Fujimoto S, Minami M, Higashikawa K, et al. Expression of TPX2 in salivary gland carcinomas. Oncol Rep. 2009;21:341\u201344.","journal-title":"Oncol Rep"},{"key":"7260_CR91","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3892\/ijo_00000286","volume":"34","author":"H Shigeishi","year":"2009","unstructured":"Shigeishi H, Fujimoto S, Hiraoka M, Ono S, Taki M, Ohta K, et al. Overexpression of the receptor for hyaluronan-mediated motility correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas. Int J Oncol. 2009;34:1565\u201371. https:\/\/doi.org\/10.3892\/ijo_00000286.","journal-title":"Int J Oncol"},{"key":"7260_CR92","doi-asserted-by":"publisher","first-page":"1610481","DOI":"10.3389\/pore.2022.1610481","volume":"28","author":"Z Fang","year":"2022","unstructured":"Fang Z, Wang F, Zhang M, Huang H, Lin Z. Identification of co-expression modules and genes associated with tumor progression in oral squamous cell carcinoma. Pathol Oncol Res. 2022;28:1610481. https:\/\/doi.org\/10.3389\/pore.2022.1610481.","journal-title":"Pathol Oncol Res"},{"key":"7260_CR93","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/S1470-2045(17)30421-7","volume":"18","author":"KJ Harrington","year":"2017","unstructured":"Harrington KJ, Ferris RL, Blumenschein G, Colevas AD, Fayette J, Licitra L, et al. Nivolumab versus standard, single-agent therapy of investigator\u2019s choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. The Lancet Oncol. 2017;18:1104\u201315. https:\/\/doi.org\/10.1016\/S1470-2045(17)30421-7.","journal-title":"The Lancet Oncol"},{"key":"7260_CR94","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.oraloncology.2018.04.008","volume":"81","author":"RL Ferris","year":"2018","unstructured":"Ferris RL, Blumenschein G, Fayette J, Guigay J, Colevas AD, Licitra L, et al. Nivolumab vs investigator\u2019s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression. Oral Oncol. 2018;81:45\u201351. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.04.008.","journal-title":"Oral Oncol"},{"key":"7260_CR95","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.cell.2021.02.011","volume":"184","author":"M Dougan","year":"2021","unstructured":"Dougan M, Luoma AM, Dougan SK, Wucherpfennig KW. Understanding and treating the inflammatory adverse events of cancer immunotherapy. Cell. 2021;184:1575\u201388. https:\/\/doi.org\/10.1016\/j.cell.2021.02.011.","journal-title":"Cell"},{"key":"7260_CR96","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00520-023-08083-w","volume":"31","author":"DC Guven","year":"2023","unstructured":"Guven DC, Erul E, Kaygusuz Y, Akagunduz B, Kilickap S, De Luca R, et al. Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data. Supportive Care In Cancer. 2023;31:624. https:\/\/doi.org\/10.1007\/s00520-023-08083-w.","journal-title":"Supportive Care In Cancer"},{"key":"7260_CR97","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41568-022-00531-9","volume":"23","author":"AT Ruffin","year":"2023","unstructured":"Ruffin AT, Li H, Vujanovic L, Zandberg DP, Ferris RL, Bruno TC. Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment. Nat Rev Cancer. 2023;23:173\u201388. https:\/\/doi.org\/10.1038\/s41568-022-00531-9.","journal-title":"Nat Rev Cancer"},{"key":"7260_CR98","doi-asserted-by":"publisher","first-page":"107327482412879","DOI":"10.1177\/10732748241287904","volume":"31","author":"H Zhang","year":"2024","unstructured":"Zhang H, Xu Y, Han H, Ye X, Cheng L, Shen Y, et al. Comprehensive analysis identifies hyaluronan mediated motility receptor and cell division cycle 25C as potential prognostic biomarkers in head and neck squamous cell carcinoma. Cancer Control: J Moffitt Cancer Cent. 2024;31:10732748241287904. https:\/\/doi.org\/10.1177\/10732748241287904.","journal-title":"Cancer Control: J Moffitt Cancer Cent"},{"key":"7260_CR99","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/odi.13766","volume":"28","author":"S-W Zhu","year":"2022","unstructured":"Zhu S-W, Wang S, Wu Z-Z, Yang Q-C, Chen D-R, Wan S-C, et al. Overexpression of CD168 is related to poor prognosis in oral squamous cell carcinoma. Oral Dis. 2022;28:364\u201372. https:\/\/doi.org\/10.1111\/odi.13766.","journal-title":"Oral Dis"},{"key":"7260_CR100","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. The Lancet. 2021;397:1750\u201369. https:\/\/doi.org\/10.1016\/S0140-6736(20)32381-3.","journal-title":"The Lancet"},{"key":"7260_CR101","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng L-W, Ding Y, Chen Y-F, Cai Y-W, Wang L-P, et al. Breast cancer: pathogenesis and treatments. Signal Transduct And Targeted Ther. 2025;10:49. https:\/\/doi.org\/10.1038\/s41392-024-02108-4.","journal-title":"Signal Transduct And Targeted Ther"},{"key":"7260_CR102","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J For Clinicians. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA: A Cancer J For Clinicians"},{"key":"7260_CR103","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cac2.12207","volume":"41","author":"S Lei","year":"2021","unstructured":"Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, et al. Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (lond). 2021;41:1183\u201394. https:\/\/doi.org\/10.1002\/cac2.12207.","journal-title":"Cancer Commun (lond)"},{"key":"7260_CR104","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41597-023-02253-5","volume":"10","author":"Y Xu","year":"2023","unstructured":"Xu Y, Gong M, Wang Y, Yang Y, Liu S, Zeng Q. Global trends and forecasts of breast cancer incidence and deaths. Sci Data. 2023;10:334. https:\/\/doi.org\/10.1038\/s41597-023-02253-5.","journal-title":"Sci Data"},{"key":"7260_CR105","doi-asserted-by":"publisher","first-page":"102924","DOI":"10.1016\/j.ctrv.2025.102924","volume":"135","author":"TK Sahin","year":"2025","unstructured":"Sahin TK, Rizzo A, Guven DC, Aksoy S. Post-progression treatment options after CDK4\/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer. Cancer Treat Rev. 2025;135:102924. https:\/\/doi.org\/10.1016\/j.ctrv.2025.102924.","journal-title":"Cancer Treat Rev"},{"key":"7260_CR106","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:2402\u201316. https:\/\/doi.org\/10.1001\/jama.2017.7112.","journal-title":"JAMA"},{"key":"7260_CR107","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s44178-022-00007-8","volume":"1","author":"J Wu","year":"2022","unstructured":"Wu J, Fan D, Shao Z, Xu B, Ren G, Jiang Z, et al. CACA guidelines for holistic integrative management of breast cancer. Holist Intgr Oncol. 2022;1:7. https:\/\/doi.org\/10.1007\/s44178-022-00007-8.","journal-title":"Holist Intgr Oncol"},{"key":"7260_CR108","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1158\/0008-5472.850.65.3","volume":"65","author":"CA Maxwell","year":"2005","unstructured":"Maxwell CA, Keats JJ, Belch AR, Pilarski LM, Reiman T. Receptor for hyaluronan-mediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity. Cancer Res. 2005;65:850\u201360.","journal-title":"Cancer Res"},{"key":"7260_CR109","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1084\/jem.183.4.1663","volume":"183","author":"S Mohapatra","year":"1996","unstructured":"Mohapatra S, Yang X, Wright JA, Turley EA, Greenberg AH. Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression. J Exp Med. 1996;183:1663\u201368. https:\/\/doi.org\/10.1084\/jem.183.4.1663.","journal-title":"J Exp Med"},{"key":"7260_CR110","doi-asserted-by":"publisher","first-page":"32461","DOI":"10.18632\/oncotarget.15688","volume":"8","author":"Z He","year":"2017","unstructured":"He Z, Kannan N, Nemirovsky O, Chen H, Connell M, Taylor B, et al. BRCA1 controls the cell division axis and governs ploidy and phenotype in human mammary cells. Oncotarget. 2017;8:32461\u201375. https:\/\/doi.org\/10.18632\/oncotarget.15688.","journal-title":"Oncotarget"},{"key":"7260_CR111","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1038\/s41467-022-29335-z","volume":"13","author":"F Mateo","year":"2022","unstructured":"Mateo F, He Z, Mei L, de Garibay GR, Herranz C, Garc\u00eda N, et al. Modification of BRCA1-associated breast cancer risk by HMMR overexpression. Nat Commun. 2022;13:1895. https:\/\/doi.org\/10.1038\/s41467-022-29335-z.","journal-title":"Nat Commun"},{"key":"7260_CR112","doi-asserted-by":"publisher","first-page":"11186","DOI":"10.1158\/0008-5472.CAN-07-2578","volume":"67","author":"S Sankaran","year":"2007","unstructured":"Sankaran S, Crone DE, Palazzo RE, Parvin JD. Aurora-a kinase regulates breast cancer associated gene 1 inhibition of centrosome-dependent microtubule nucleation. Cancer Res. 2007;67:11186\u201394. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-2578.","journal-title":"Cancer Res"},{"key":"7260_CR113","first-page":"567","volume":"4","author":"C Wang","year":"1998","unstructured":"Wang C, Thor AD, Moore DH, Zhao Y, Kerschmann R, Stern R, et al. The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin Cancer Res: Off J Am Assoc For Cancer Res. 1998;4:567\u201376.","journal-title":"Clin Cancer Res: Off J Am Assoc For Cancer Res"},{"key":"7260_CR114","doi-asserted-by":"publisher","first-page":"16667","DOI":"10.1074\/jbc.M702078200","volume":"282","author":"SR Hamilton","year":"2007","unstructured":"Hamilton SR, Fard SF, Paiwand FF, Tolg C, Veiseh M, Wang C, et al. The hyaluronan receptors CD44 and RHAMM (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells. J Biol Chem. 2007;282:16667\u20131680. https:\/\/doi.org\/10.1074\/jbc.M702078200.","journal-title":"J Biol Chem"},{"key":"7260_CR115","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.actbio.2020.10.024","volume":"119","author":"AM Carvalho","year":"2021","unstructured":"Carvalho AM, Soares da Costa D, Paulo PMR, Reis RL, Pashkuleva I. Co-localization and crosstalk between CD44 and RHAMM depend on hyaluronan presentation. Acta Biomaterialia. 2021;119:114\u201324. https:\/\/doi.org\/10.1016\/j.actbio.2020.10.024.","journal-title":"Acta Biomaterialia"},{"key":"7260_CR116","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","volume":"19","author":"D Pan","year":"2010","unstructured":"Pan D. The hippo signaling pathway in development and cancer. Dev Cell. 2010;19:491\u2013505. https:\/\/doi.org\/10.1016\/j.devcel.2010.09.011.","journal-title":"Dev Cell"},{"key":"7260_CR117","doi-asserted-by":"publisher","unstructured":"Zhou Q, Liu X, Lv M, Sun E, Lu X, Lu C. Genes that predict poor prognosis in breast cancer via bioinformatical analysis. Biomed Res Int. 2021, 2021;6649660. https:\/\/doi.org\/10.1155\/2021\/6649660.","DOI":"10.1155\/2021\/6649660"},{"key":"7260_CR118","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jcb.30205","volume":"123","author":"I Kahl","year":"2022","unstructured":"Kahl I, Mense J, Finke C, Boller A-L, Lorber C, Gy\u0151rffy B, et al. The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients. J Cellular Biochem. 2022;123:581\u2013600. https:\/\/doi.org\/10.1002\/jcb.30205.","journal-title":"J Cellular Biochem"},{"key":"7260_CR119","doi-asserted-by":"publisher","first-page":"1361424","DOI":"10.3389\/fphar.2024.1361424","volume":"15","author":"A Shabir","year":"2024","unstructured":"Shabir A, Qayoom H, Haq BU, Abo Mansoor A, Abdelrahim A, Ahmad I, et al. Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors. Front Pharmacol. 2024;15:1361424. https:\/\/doi.org\/10.3389\/fphar.2024.1361424.","journal-title":"Front Pharmacol"},{"key":"7260_CR120","doi-asserted-by":"publisher","first-page":"25912","DOI":"10.1038\/s41598-025-10452-w","volume":"15","author":"Z Jafari","year":"2025","unstructured":"Jafari Z, Javadirad S-M, Yazdi Rouholamini SE. Adrenocortical carcinoma survival gene HMMR was identified as being targeted by fluorouracil and epirubicin using a gene coexpression network-based drug repositioning strategy. Sci Rep. 2025;15:25912. https:\/\/doi.org\/10.1038\/s41598-025-10452-w.","journal-title":"Sci Rep"},{"key":"7260_CR121","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.3390\/cancers16213600","volume":"16","author":"S Fujisawa","year":"2024","unstructured":"Fujisawa S, Takagi K, Yamaguchi-Tanaka M, Sato A, Miki Y, Miyashita M, et al. Receptor for hyaluronan mediated motility (Rhamm)\/hyaluronan axis in breast cancer chemoresistance. Cancers. 2024;16:3600. https:\/\/doi.org\/10.3390\/cancers16213600.","journal-title":"Cancers"},{"key":"7260_CR122","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/JTO.0b013e31824cc334","volume":"7","author":"RS Heist","year":"2012","unstructured":"Heist RS, Sequist LV, Engelman JA. Genetic changes in squamous cell lung cancer: a review. J Thorac Oncol. 2012;7:924\u201333. https:\/\/doi.org\/10.1097\/JTO.0b013e31824cc334.","journal-title":"J Thorac Oncol"},{"key":"7260_CR123","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1016\/j.cell.2021.07.016","volume":"184","author":"S Satpathy","year":"2021","unstructured":"Satpathy S, Krug K, Jean Beltran PM, Savage SR, Petralia F, Kumar-Sinha C, et al. A proteogenomic portrait of lung squamous cell carcinoma. Cell. 2021;184:4348\u201371.e40. https:\/\/doi.org\/10.1016\/j.cell.2021.07.016.","journal-title":"Cell"},{"key":"7260_CR124","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41392-022-01200-x","volume":"7","author":"Z Niu","year":"2022","unstructured":"Niu Z, Jin R, Zhang Y, Li H. Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials. Signal Transduct And Targeted Ther. 2022;7:353. https:\/\/doi.org\/10.1038\/s41392-022-01200-x.","journal-title":"Signal Transduct And Targeted Ther"},{"key":"7260_CR125","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/cac2.12226","volume":"41","author":"S Shang","year":"2021","unstructured":"Shang S, Liu J, Verma V, Wu M, Welsh J, Yu J, et al. Combined treatment of non-small cell lung cancer using radiotherapy and immunotherapy: challenges and updates. Cancer Commun (lond). 2021;41:1086\u201399. https:\/\/doi.org\/10.1002\/cac2.12226.","journal-title":"Cancer Commun (lond)"},{"key":"7260_CR126","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1158\/0008-5472.CAN-16-1978","volume":"77","author":"LE Stevens","year":"2017","unstructured":"Stevens LE, Cheung WKC, Adua SJ, Arnal-Estap\u00e9 A, Zhao M, Liu Z, et al. Extracellular matrix receptor expression in subtypes of lung adenocarcinoma potentiates outgrowth of micrometastases. Cancer Res. 2017;77:1905\u201317. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1978.","journal-title":"Cancer Res"},{"key":"7260_CR127","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.7150\/ijbs.104097","volume":"21","author":"J Zhang","year":"2025","unstructured":"Zhang J, Zhang M, Qiu A, Li C, Chen Q, Li J, et al. N6-methyladenosine reader IGF2BP2-modified HMMR promotes non-small cell lung cancer metastasis via interaction with MAP4K4. Int J Biol Sci. 2025;21:1391\u2013409. https:\/\/doi.org\/10.7150\/ijbs.104097.","journal-title":"Int J Biol Sci"},{"key":"7260_CR128","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12935-020-01711-z","volume":"21","author":"M Li","year":"2021","unstructured":"Li M, Jin S, Cao Y, Xu J, Zhu S, Li Z. Emodin regulates cell cycle of non-small lung cancer (NSCLC) cells through hyaluronan synthase 2 (HA2)-HA-CD44\/receptor for hyaluronic acid-mediated motility (RHAMM) interaction-dependent signaling pathway. Cancer Cell Int. 2021;21:19. https:\/\/doi.org\/10.1186\/s12935-020-01711-z.","journal-title":"Cancer Cell Int"},{"key":"7260_CR129","doi-asserted-by":"publisher","first-page":"26927","DOI":"10.18632\/oncotarget.15879","volume":"8","author":"JM Song","year":"2017","unstructured":"Song JM, Molla K, Anandharaj A, Cornax I, O Sullivan MG, Kirtane AR, et al. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44\/RHAMM signaling. Oncotarget. 2017;8:26927\u201340. https:\/\/doi.org\/10.18632\/oncotarget.15879.","journal-title":"Oncotarget"},{"key":"7260_CR130","doi-asserted-by":"publisher","first-page":"11970","DOI":"10.18632\/aging.205159","volume":"15","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Shen Y, Fang Q, Duan S, Wang Y, Dai X, et al. Identification of epithelial-mesenchymal transition-related biomarkers in lung adenocarcinoma using bioinformatics and lab experiments. Aging (albany NY). 2023;15:11970\u20131184. https:\/\/doi.org\/10.18632\/aging.205159.","journal-title":"Aging (albany NY)"},{"key":"7260_CR131","doi-asserted-by":"publisher","first-page":"846536","DOI":"10.3389\/fonc.2022.846536","volume":"12","author":"X Jiang","year":"2022","unstructured":"Jiang X, Tang L, Yuan Y, Wang J, Zhang D, Qian K, et al. NcRNA-mediated high expression of HMMR as a prognostic biomarker correlated with cell proliferation and cell migration in lung adenocarcinoma. Front Oncol. 2022;12:846536. https:\/\/doi.org\/10.3389\/fonc.2022.846536.","journal-title":"Front Oncol"},{"key":"7260_CR132","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fonc.2019.00693","volume":"9","author":"R He","year":"2019","unstructured":"He R, Zuo S. A robust 8-gene prognostic signature for early-stage non-small cell lung cancer. Front Oncol. 2019;9:693. https:\/\/doi.org\/10.3389\/fonc.2019.00693.","journal-title":"Front Oncol"},{"key":"7260_CR133","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jclinpath-2014-202819","volume":"68","author":"F Augustin","year":"2015","unstructured":"Augustin F, Fiegl M, Schmid T, Pomme G, Sterlacci W, Tzankov A. Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer. J Clin Pathol. 2015;68:368\u201373. https:\/\/doi.org\/10.1136\/jclinpath-2014-202819.","journal-title":"J Clin Pathol"},{"key":"7260_CR134","doi-asserted-by":"publisher","first-page":"108715","DOI":"10.1016\/j.intimp.2022.108715","volume":"107","author":"G Shan","year":"2022","unstructured":"Shan G, Meihe L, Minchao K, Rui Z, Xiaopeng W, Guangjian Z, et al. Identification and validation of osteopontin and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) for potential immunotherapeutic significance of in lung squamous cell carcinoma. Int Immunopharmacol. 2022;107:108715. https:\/\/doi.org\/10.1016\/j.intimp.2022.108715.","journal-title":"Int Immunopharmacol"},{"key":"7260_CR135","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13058-023-01652-1","volume":"25","author":"C Tolg","year":"2023","unstructured":"Tolg C, Milojevic M, Qi FW, Pavanel HA, Locke MEO, Ma J, et al. RHAMM regulates MMTV-PyMT-induced lung metastasis by connecting STING-dependent DNA damage sensing to interferon\/STAT1 pro-apoptosis signaling. Breast Cancer Res. 2023;25:74. https:\/\/doi.org\/10.1186\/s13058-023-01652-1.","journal-title":"Breast Cancer Res"},{"key":"7260_CR136","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/biomedicines9010035","volume":"9","author":"M Tsubaki","year":"2021","unstructured":"Tsubaki M, Genno S, Takeda T, Matsuda T, Kimura N, Yamashita Y, et al. Rhosin suppressed tumor cell metastasis through inhibition of rho\/YAP pathway and expression of RHAMM and CXCR4 in melanoma and breast cancer cells. Biomedicines. 2021;9:35. https:\/\/doi.org\/10.3390\/biomedicines9010035.","journal-title":"Biomedicines"},{"key":"7260_CR137","doi-asserted-by":"publisher","first-page":"e24162","DOI":"10.1016\/j.heliyon.2024.e24162","volume":"10","author":"Y Chai","year":"2024","unstructured":"Chai Y, Ma Y, Feng W, Xiang H, Lu H, Jin L. Identification and validation of a 4-extracellular matrix gene signature associated with prognosis and immune infiltration in lung adenocarcinoma. Heliyon. 2024;10:e24162. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24162.","journal-title":"Heliyon"},{"key":"7260_CR138","doi-asserted-by":"publisher","first-page":"1028440","DOI":"10.3389\/fimmu.2022.1028440","volume":"13","author":"H Zhu","year":"2022","unstructured":"Zhu H, Zheng C, Liu H, Kong F, Kong S, Chen F, et al. Significance of macrophage infiltration in the prognosis of lung adenocarcinoma patients evaluated by scRNA and bulkRNA analysis. Front Immunol. 2022;13:1028440. https:\/\/doi.org\/10.3389\/fimmu.2022.1028440.","journal-title":"Front Immunol"},{"key":"7260_CR139","doi-asserted-by":"publisher","first-page":"115346","DOI":"10.1016\/j.jpba.2023.115346","volume":"229","author":"G Shan","year":"2023","unstructured":"Shan G, Minchao K, Jizhao W, Rui Z, Guangjian Z, Jin Z, et al. Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR\/ferroptosis in lung squamous cell carcinoma. J Pharm And Biomed Anal. 2023;229:115346. https:\/\/doi.org\/10.1016\/j.jpba.2023.115346.","journal-title":"J Pharm And Biomed Anal"},{"key":"7260_CR140","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/bju.13123","volume":"117","author":"J Schalken","year":"2016","unstructured":"Schalken J, Fitzpatrick JM. Enzalutamide: targeting the androgen signalling pathway in metastatic castration-resistant prostate cancer. BJU Int. 2016;117:215\u201325. https:\/\/doi.org\/10.1111\/bju.13123.","journal-title":"BJU Int"},{"key":"7260_CR141","doi-asserted-by":"publisher","first-page":"e62592","DOI":"10.7554\/eLife.62592","volume":"10","author":"JL Gillis","year":"2021","unstructured":"Gillis JL, Hinneh JA, Ryan NK, Irani S, Moldovan M, Quek L-E, et al. A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth. eLife. 2021;10:e62592. https:\/\/doi.org\/10.7554\/eLife.62592.","journal-title":"eLife"},{"key":"7260_CR142","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/bju.12339","volume":"113","author":"F Korkes","year":"2014","unstructured":"Korkes F, de Castro MG, de Cassio Zequi S, Nardi L, Del Giglio A, de Lima Pompeo AC. Hyaluronan-mediated motility receptor (RHAMM) immunohistochemical expression and androgen deprivation in normal peritumoral, hyperplasic and neoplastic prostate tissue. BJU Int. 2014;113:822\u201329. https:\/\/doi.org\/10.1111\/bju.12339.","journal-title":"BJU Int"},{"key":"7260_CR143","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.21037\/tau-24-359","volume":"13","author":"H Tang","year":"2024","unstructured":"Tang H, Zhou F, Hu W, Zhang C, Tao J, Xing F, et al. Identification of BIRC5 and HMMR as prognostic biomarkers for immune infiltration in prostate cancer. Transl Androl And Urology. 2024;13:2482\u201397. https:\/\/doi.org\/10.21037\/tau-24-359.","journal-title":"Transl Androl And Urology"},{"key":"7260_CR144","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/cncr.28646","volume":"120","author":"AE Rizzardi","year":"2014","unstructured":"Rizzardi AE, Vogel RI, Koopmeiners JS, Forster CL, Marston LO, Rosener NK, et al. Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors. Cancer. 2014;120:1800\u201309. https:\/\/doi.org\/10.1002\/cncr.28646.","journal-title":"Cancer"},{"key":"7260_CR145","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/carcin\/bgl134","volume":"28","author":"S-L Lin","year":"2007","unstructured":"Lin S-L, Chang D, Ying S-Y. Hyaluronan stimulates transformation of androgen-independent prostate cancer. Carcinogenesis. 2007;28:310\u201320. https:\/\/doi.org\/10.1093\/carcin\/bgl134.","journal-title":"Carcinogenesis"},{"key":"7260_CR146","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1593\/neo.09694","volume":"11","author":"KM Gust","year":"2009","unstructured":"Gust KM, Hofer MD, Perner SR, Kim R, Chinnaiyan AM, Varambally S, et al. RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease. Neoplasia. 2009;11:956\u201363. https:\/\/doi.org\/10.1593\/neo.09694.","journal-title":"Neoplasia"},{"key":"7260_CR147","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41416-023-02406-8","volume":"129","author":"JA Hinneh","year":"2023","unstructured":"Hinneh JA, Gillis JL, Mah CY, Irani S, Shrestha RK, Ryan NK, et al. Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer. Br J Cancer. 2023;129:1350\u201361. https:\/\/doi.org\/10.1038\/s41416-023-02406-8.","journal-title":"Br J Cancer"},{"key":"7260_CR148","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s12272-023-01461-2","volume":"46","author":"M Jiang","year":"2023","unstructured":"Jiang M, Poudel S, Song K. Androgen receptor and hyaluronan-mediated motility receptor as new molecular targets of baicalein: new molecular mechanisms for its anticancer properties. Archiv Pharmacal Res. 2023;46:679\u201393. https:\/\/doi.org\/10.1007\/s12272-023-01461-2.","journal-title":"Archiv Pharmacal Res"},{"key":"7260_CR149","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/s0301-472x(02)00874-3","volume":"30","author":"J Greiner","year":"2002","unstructured":"Greiner J, Ringhoffer M, Taniguchi M, Schmitt A, Kirchner D, Kr\u00e4hn G, et al. Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia. Exp Hematol. 2002;30:1029\u201335. https:\/\/doi.org\/10.1016\/s0301-472x(02)00874-3.","journal-title":"Exp Hematol"},{"key":"7260_CR150","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1182\/blood.V93.5.1684","volume":"93","author":"M Crainie","year":"1999","unstructured":"Crainie M, Belch AR, Mant MJ, Pilarski LM. Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variants. Blood. 1999;93:1684\u201396.","journal-title":"Blood"},{"key":"7260_CR151","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/leu.2008.338","volume":"23","author":"K Giannopoulos","year":"2009","unstructured":"Giannopoulos K, Mertens D, B\u00fchler A, Barth TFE, Idler I, M\u00f6ller P, et al. The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia. Leukemia. 2009;23:519\u201327. https:\/\/doi.org\/10.1038\/leu.2008.338.","journal-title":"Leukemia"},{"key":"7260_CR152","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3892\/or.2016.5226","volume":"37","author":"J \u0160mahelov\u00e1","year":"2017","unstructured":"\u0160mahelov\u00e1 J, Ka\u0161t\u00e1nkov\u00e1 I, Pol\u00e1kov\u00e1 KM, Klamov\u00e1 H, Zemanov\u00e1 K, Tachezy R, et al. Expression of genes encoding centrosomal proteins and the humoral response against these proteins in chronic myeloid leukemia. Oncol Rep. 2017;37:547\u201354. https:\/\/doi.org\/10.3892\/or.2016.5226.","journal-title":"Oncol Rep"},{"key":"7260_CR153","doi-asserted-by":"publisher","first-page":"84847","DOI":"10.18632\/oncotarget.11215","volume":"8","author":"M Schmitt","year":"2017","unstructured":"Schmitt M, H\u00fcckelhoven AG, Hundemer M, Schmitt A, Lipp S, Emde M, et al. Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial. Oncotarget. 2017;8:84847\u201362. https:\/\/doi.org\/10.18632\/oncotarget.11215.","journal-title":"Oncotarget"},{"key":"7260_CR154","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1182\/blood-2003-11-4079","volume":"104","author":"CA Maxwell","year":"2004","unstructured":"Maxwell CA, Rasmussen E, Zhan F, Keats JJ, Adamia S, Strachan E, et al. RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma. Blood. 2004;104:1151\u201358. https:\/\/doi.org\/10.1182\/blood-2003-11-4079.","journal-title":"Blood"},{"key":"7260_CR155","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41408-023-00791-0","volume":"13","author":"D Ogiya","year":"2023","unstructured":"Ogiya D, Chyra Z, Verselis SJ, O\u2019Keefe M, Cobb J, Abiatari I, et al. Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics. Blood Cancer J. 2023;13:23. https:\/\/doi.org\/10.1038\/s41408-023-00791-0.","journal-title":"Blood Cancer J"},{"key":"7260_CR156","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1182\/blood-2004-12-4787","volume":"106","author":"J Greiner","year":"2005","unstructured":"Greiner J, Li L, Ringhoffer M, Barth TFE, Giannopoulos K, Guillaume P, et al. Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM\/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia. Blood. 2005;106:938\u201345. https:\/\/doi.org\/10.1182\/blood-2004-12-4787.","journal-title":"Blood"},{"key":"7260_CR157","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/ijc.11200","volume":"106","author":"J Greiner","year":"2003","unstructured":"Greiner J, Ringhoffer M, Taniguchi M, Hauser T, Schmitt A, D\u00f6hner H, et al. Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia. Int J Cancer. 2003;106:224\u201331. https:\/\/doi.org\/10.1002\/ijc.11200.","journal-title":"Int J Cancer"},{"key":"7260_CR158","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3324\/haematol.2009.014704","volume":"95","author":"J Greiner","year":"2010","unstructured":"Greiner J, Schmitt A, Giannopoulos K, Rojewski MT, G\u00f6tz M, Funk I, et al. High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma. Haematologica. 2010;95:1191\u201397. https:\/\/doi.org\/10.3324\/haematol.2009.014704.","journal-title":"Haematologica"},{"key":"7260_CR159","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1182\/blood-2007-07-099366","volume":"111","author":"M Schmitt","year":"2008","unstructured":"Schmitt M, Schmitt A, Rojewski MT, Chen J, Giannopoulos K, Fei F, et al. RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses. Blood. 2008;111:1357\u201365. https:\/\/doi.org\/10.1182\/blood-2007-07-099366.","journal-title":"Blood"},{"key":"7260_CR160","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","volume":"26","author":"PJ Roberts","year":"2007","unstructured":"Roberts PJ, Der CJ. Targeting the raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26:3291\u2013310. https:\/\/doi.org\/10.1038\/sj.onc.1210422.","journal-title":"Oncogene"},{"key":"7260_CR161","doi-asserted-by":"publisher","first-page":"38509","DOI":"10.1074\/jbc.M111.275875","volume":"286","author":"K Kouvidi","year":"2011","unstructured":"Kouvidi K, Berdiaki A, Nikitovic D, Katonis P, Afratis N, Hascall VC, et al. Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion. J Biol Chem. 2011;286:38509\u201320. https:\/\/doi.org\/10.1074\/jbc.M111.275875.","journal-title":"J Biol Chem"},{"key":"7260_CR162","doi-asserted-by":"publisher","first-page":"9527","DOI":"10.2147\/OTT.S224013","volume":"12","author":"X Bai","year":"2019","unstructured":"Bai X, Yi M, Jiao Y, Chu Q, Wu K. Blocking TGF-\u03b2 signaling to enhance the efficacy of immune checkpoint inhibitor. oncotargets And Ther. 2019;12:9527\u201338. https:\/\/doi.org\/10.2147\/OTT.S224013.","journal-title":"oncotargets And Ther"},{"key":"7260_CR163","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1096\/fj.201802186R","volume":"33","author":"H Zhang","year":"2019","unstructured":"Zhang H, Ren L, Ding Y, Li F, Chen X, Ouyang Y, et al. Hyaluronan-mediated motility receptor confers resistance to chemotherapy via TGF\u03b2\/Smad2-induced epithelial-mesenchymal transition in gastric cancer. Faseb J. 2019;33:6365\u201377. https:\/\/doi.org\/10.1096\/fj.201802186R.","journal-title":"Faseb J"},{"key":"7260_CR164","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/aps.2012.72","volume":"33","author":"I Pal","year":"2012","unstructured":"Pal I, Mandal M. PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes. Acta Pharmacologica Sin. 2012;33:1441\u201358. https:\/\/doi.org\/10.1038\/aps.2012.72.","journal-title":"Acta Pharmacologica Sin"},{"key":"7260_CR165","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.3390\/ijms25147607","volume":"25","author":"DL Vitale","year":"2024","unstructured":"Vitale DL, Parnigoni A, Viola M, Karousou E, Sevic I, Moretto P, et al. Deciphering drug resistance: investigating the emerging role of hyaluronan metabolism and signaling and tumor extracellular matrix in cancer chemotherapy. Int J Mol Sci. 2024;25:7607. https:\/\/doi.org\/10.3390\/ijms25147607.","journal-title":"Int J Mol Sci"},{"key":"7260_CR166","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1158\/0008-5472.CAN-10-4610","volume":"71","author":"A Benitez","year":"2011","unstructured":"Benitez A, Yates TJ, Lopez LE, Cerwinka WH, Bakkar A, Lokeshwar VB. Targeting hyaluronidase for cancer therapy: antitumor activity of sulfated hyaluronic acid in prostate cancer cells. Cancer Res. 2011;71:4085\u201395. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4610.","journal-title":"Cancer Res"},{"key":"7260_CR167","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00418-017-1559-3","volume":"148","author":"M Mascar\u00f3","year":"2017","unstructured":"Mascar\u00f3 M, Pibuel MA, Lompard\u00eda SL, D\u00edaz M, Zotta E, Bianconi MI, et al. Low molecular weight hyaluronan induces migration of human choriocarcinoma JEG-3 cells mediated by RHAMM as well as by PI3K and MAPK pathways. Histochem And Cell Biol. 2017;148:173\u201387. https:\/\/doi.org\/10.1007\/s00418-017-1559-3.","journal-title":"Histochem And Cell Biol"},{"key":"7260_CR168","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","volume":"10","author":"J Kwon","year":"2020","unstructured":"Kwon J, Bakhoum SF. The cytosolic DNA-sensing cGAS-STING pathway in cancer. Cancer Discov. 2020;10:26\u201339. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0761.","journal-title":"Cancer Discov"},{"key":"7260_CR169","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1042\/BST20180334","volume":"47","author":"MZ Johan","year":"2019","unstructured":"Johan MZ, Samuel MS. Rho-ROCK signaling regulates tumor-microenvironment interactions. Biochemical Soc Trans. 2019;47:101\u201308. https:\/\/doi.org\/10.1042\/BST20180334.","journal-title":"Biochemical Soc Trans"},{"key":"7260_CR170","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","volume":"6","author":"F Yu","year":"2021","unstructured":"Yu F, Yu C, Li F, Zuo Y, Wang Y, Yao L, et al. Wnt\/\u03b2-catenin signaling in cancers and targeted therapies. Signal Transduct And Targeted Ther. 2021;6:307. https:\/\/doi.org\/10.1038\/s41392-021-00701-5.","journal-title":"Signal Transduct And Targeted Ther"},{"key":"7260_CR171","doi-asserted-by":"publisher","first-page":"8937","DOI":"10.1007\/s11033-023-08763-0","volume":"50","author":"A Berdiaki","year":"2023","unstructured":"Berdiaki A, Thrapsanioti L-N, Giatagana E-M, Karamanos NK, Savani RC, Tzanakakis GN, et al. RHAMM\/hyaluronan inhibit \u03b2-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth. Mol Biol Rep. 2023;50:8937\u201347. https:\/\/doi.org\/10.1007\/s11033-023-08763-0.","journal-title":"Mol Biol Rep"},{"key":"7260_CR172","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.bbagen.2016.01.019","volume":"1860","author":"K Kouvidi","year":"2016","unstructured":"Kouvidi K, Berdiaki A, Tzardi M, Karousou E, Passi A, Nikitovic D, et al. Receptor for hyaluronic acid-mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a \u03b2-catenin\/c-myc signaling axis. Biochim Et Biophys Acta. 2016;1860:814\u201324. https:\/\/doi.org\/10.1016\/j.bbagen.2016.01.019.","journal-title":"Biochim Et Biophys Acta"},{"key":"7260_CR173","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3892\/ol.2020.12060","volume":"20","author":"X-B Cheng","year":"2020","unstructured":"Cheng X-B, Wang S, Yang H, Tong H, Shi G, Wu L, et al. Negative regulation between the expression levels of receptor for hyaluronic acid-mediated motility and hyaluronan leads to cell migration in pancreatic cancer. Oncol Lett. 2020;20:199. https:\/\/doi.org\/10.3892\/ol.2020.12060.","journal-title":"Oncol Lett"},{"key":"7260_CR174","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12943-019-1018-y","volume":"18","author":"S Choi","year":"2019","unstructured":"Choi S, Wang D, Chen X, Tang LH, Verma A, Chen Z, et al. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression. Mol Cancer. 2019;18:92. https:\/\/doi.org\/10.1186\/s12943-019-1018-y.","journal-title":"Mol Cancer"},{"key":"7260_CR175","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1158\/1078-0432.CCR-17-3401","volume":"24","author":"M Wartenberg","year":"2018","unstructured":"Wartenberg M, Cibin S, Zlobec I, Vassella E, Eppenberger-Castori S, Terracciano L, et al. Integrated genomic and immunophenotypic classification of pancreatic cancer reveals three distinct subtypes with prognostic\/predictive significance. Clin Cancer Res. 2018;24:4444\u201354. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3401.","journal-title":"Clin Cancer Res"},{"key":"7260_CR176","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.7150\/jca.12990","volume":"6","author":"X-B Cheng","year":"2015","unstructured":"Cheng X-B, Sato N, Kohi S, Koga A, Hirata K. Receptor for hyaluronic acid-mediated motility is associated with poor survival in pancreatic ductal adenocarcinoma. J Cancer. 2015;6:1093\u201398. https:\/\/doi.org\/10.7150\/jca.12990.","journal-title":"J Cancer"},{"key":"7260_CR177","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12307-019-00224-2","volume":"12","author":"JS Hartheimer","year":"2019","unstructured":"Hartheimer JS, Park S, Rao SS, Kim Y. Targeting hyaluronan interactions for glioblastoma stem cell therapy. Cancer Microenvironment. 2019;12:47\u201356. https:\/\/doi.org\/10.1007\/s12307-019-00224-2.","journal-title":"Cancer Microenvironment"},{"key":"7260_CR178","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.neo.2018.02.010","volume":"20","author":"J Li","year":"2018","unstructured":"Li J, Ji X, Wang H. Targeting long noncoding RNA HMMR-AS1 suppresses and radiosensitizes glioblastoma. Neoplasia (new York, NY). 2018;20:456\u201366. https:\/\/doi.org\/10.1016\/j.neo.2018.02.010.","journal-title":"Neoplasia (new York, NY)"},{"key":"7260_CR179","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1158\/0008-5472.CAN-13-2103","volume":"74","author":"J Tilghman","year":"2014","unstructured":"Tilghman J, Wu H, Sang Y, Shi X, Guerrero-Cazares H, Quinones-Hinojosa A, et al. HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells. Cancer Res. 2014;74:3168\u201379. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2103.","journal-title":"Cancer Res"},{"key":"7260_CR180","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1136\/jmg-2023-109517","volume":"61","author":"LF Thean","year":"2024","unstructured":"Thean LF, Wong M, Lo M, Tan I, Wong E, Gao F, et al. Functional annotation with expression validation identifies novel metastasis-relevant genes from post-GWAS risk loci in sporadic colorectal carcinomas. J Med Genet. 2024;61:276\u201383. https:\/\/doi.org\/10.1136\/jmg-2023-109517.","journal-title":"J Med Genet"},{"key":"7260_CR181","doi-asserted-by":"publisher","first-page":"23661","DOI":"10.1038\/s41598-024-72674-8","volume":"14","author":"J Liu","year":"2024","unstructured":"Liu J, Yang H, Li P, Zhou Y, Zhang Z, Zeng Q, et al. Microarray analysis points to LMNB1 and JUN as potential target genes for predicting metastasis promotion by etoposide in colorectal cancer. Sci Rep. 2024;14:23661. https:\/\/doi.org\/10.1038\/s41598-024-72674-8.","journal-title":"Sci Rep"},{"key":"7260_CR182","doi-asserted-by":"publisher","first-page":"70617","DOI":"10.18632\/oncotarget.19904","volume":"8","author":"V Mele","year":"2017","unstructured":"Mele V, Sokol L, K\u00f6lzer VH, Pfaff D, Muraro MG, Keller I, et al. The hyaluronan-mediated motility receptor RHAMM promotes growth, invasiveness and dissemination of colorectal cancer. Oncotarget. 2017;8:70617\u201329. https:\/\/doi.org\/10.18632\/oncotarget.19904.","journal-title":"Oncotarget"},{"key":"7260_CR183","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.humpath.2015.07.010","volume":"46","author":"VH Koelzer","year":"2015","unstructured":"Koelzer VH, Huber B, Mele V, Iezzi G, Trippel M, Karamitopoulou E, et al. Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers. Hum Pathol. 2015;46:1573\u201381. https:\/\/doi.org\/10.1016\/j.humpath.2015.07.010.","journal-title":"Hum Pathol"},{"key":"7260_CR184","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1111\/cas.15795","volume":"114","author":"M Nakano","year":"2023","unstructured":"Nakano M, Taguchi R, Kikushige Y, Isobe T, Miyawaki K, Mizuno S, et al. RHAMM marks proliferative subpopulation of human colorectal cancer stem cells. Cancer Sci. 2023;114:2895\u2013906. https:\/\/doi.org\/10.1111\/cas.15795.","journal-title":"Cancer Sci"},{"key":"7260_CR185","doi-asserted-by":"publisher","first-page":"e75681","DOI":"10.1371\/journal.pone.0075681","volume":"8","author":"C Niedworok","year":"2013","unstructured":"Niedworok C, Kretschmer I, R\u00f6ck K, Vom Dorp F, Szarvas T, He\u00df J, et al. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder. PLoS One. 2013;8:e75681. https:\/\/doi.org\/10.1371\/journal.pone.0075681.","journal-title":"PLoS One"},{"key":"7260_CR186","doi-asserted-by":"publisher","first-page":"712795","DOI":"10.3389\/fonc.2021.712795","volume":"11","author":"J Shi","year":"2021","unstructured":"Shi J, Chen Y, Wang Z, Guo J, Tong C, Tong J, et al. Comprehensive bioinformatics analysis to identify the gene HMMR associated with lung adenocarcinoma prognosis and its mechanism of action in multiple cancers. Front Oncol. 2021;11:712795. https:\/\/doi.org\/10.3389\/fonc.2021.712795.","journal-title":"Front Oncol"},{"key":"7260_CR187","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/mc.22961","volume":"58","author":"H Li","year":"2019","unstructured":"Li H, Shukla S, Frappart L, Herrlich P, Ploubidou A. Cd44 deletion suppresses atypia in the precancerous mouse testis. Mol Carcinog. 2019;58:621\u201326. https:\/\/doi.org\/10.1002\/mc.22961.","journal-title":"Mol Carcinog"},{"key":"7260_CR188","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1158\/1078-0432.CCR-07-1305","volume":"14","author":"KK Mantripragada","year":"2008","unstructured":"Mantripragada KK, Spurlock G, Kluwe L, Chuzhanova N, Ferner RE, Frayling IM, et al. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization. Clin Cancer Res. 2008;14:1015\u201324. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-1305.","journal-title":"Clin Cancer Res"},{"key":"7260_CR189","doi-asserted-by":"publisher","first-page":"e2300693","DOI":"10.1002\/adbi.202300693","volume":"8","author":"C Tolg","year":"2024","unstructured":"Tolg C, Hill KA, Turley EA. CD44 and RHAMM are microenvironmental sensors with dual metastasis promoter and suppressor functions. Adv Biol. 2024;8:e2300693. https:\/\/doi.org\/10.1002\/adbi.202300693.","journal-title":"Adv Biol"},{"key":"7260_CR190","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s12672-025-03314-4","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang P, Liu H, Feng H, Cao M, Zhang Z, et al. Identification of glycolysis-related molecular subtypes and prognostic model in intrahepatic cholangiocarcinoma. Discover Oncol. 2025;16:1577. https:\/\/doi.org\/10.1007\/s12672-025-03314-4.","journal-title":"Discover Oncol"},{"key":"7260_CR191","doi-asserted-by":"publisher","first-page":"e0120020","DOI":"10.1371\/journal.pone.0120020","volume":"10","author":"I Blanco","year":"2015","unstructured":"Blanco I, Kuchenbaecker K, Cuadras D, Wang X, Barrowdale D, de Garibay GR, et al. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1\/2 mutation carriers. PLoS One. 2015;10:e0120020. https:\/\/doi.org\/10.1371\/journal.pone.0120020.","journal-title":"PLoS One"},{"key":"7260_CR192","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrc.2018.11","volume":"18","author":"CR Leemans","year":"2018","unstructured":"Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018;18:269\u201382. https:\/\/doi.org\/10.1038\/nrc.2018.11.","journal-title":"Nat Rev Cancer"},{"key":"7260_CR193","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13046-024-03028-5","volume":"43","author":"A Tosi","year":"2024","unstructured":"Tosi A, Parisatto B, Gaffo E, Bortoluzzi S, Rosato A. A paclitaxel-hyaluronan conjugate (ONCOFID-P-BTM) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the tumor microenvironment. J Exp Clin Cancer Res: CR. 2024;43:109. https:\/\/doi.org\/10.1186\/s13046-024-03028-5.","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"7260_CR194","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.clnesp.2025.03.023","volume":"68","author":"O Bas","year":"2025","unstructured":"Bas O, Sahin TK, Karahan L, Rizzo A, Guven DC. Prognostic significance of the cachexia index (CXI) in patients with cancer: a systematic review and meta-analysis. Clin Nutr ESPEN. 2025;68:240\u201347. https:\/\/doi.org\/10.1016\/j.clnesp.2025.03.023.","journal-title":"Clin Nutr ESPEN"},{"key":"7260_CR195","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.3390\/cancers16213689","volume":"16","author":"TK Sahin","year":"2024","unstructured":"Sahin TK, Ayasun R, Rizzo A, Guven DC. Prognostic value of neutrophil-to-eosinophil ratio (NER) in cancer: a systematic review and meta-analysis. Cancers. 2024;16:3689. https:\/\/doi.org\/10.3390\/cancers16213689.","journal-title":"Cancers"},{"key":"7260_CR196","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41416-022-01999-w","volume":"128","author":"MA Pibuel","year":"2023","unstructured":"Pibuel MA, Poodts D, Molinari Y, D\u00edaz M, Amoia S, Byrne A, et al. The importance of RHAMM in the normal brain and gliomas: physiological and pathological roles. Br J Cancer. 2023;128:12\u201320. https:\/\/doi.org\/10.1038\/s41416-022-01999-w.","journal-title":"Br J Cancer"},{"key":"7260_CR197","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1165\/rcmb.2006-0413OC","volume":"37","author":"D Manzanares","year":"2007","unstructured":"Manzanares D, Monzon M-E, Savani RC, Salathe M. Apical oxidative hyaluronan degradation stimulates airway ciliary beating via RHAMM and RON. Am J Respir Cell And Mol Biol. 2007;37:160\u201368. https:\/\/doi.org\/10.1165\/rcmb.2006-0413OC.","journal-title":"Am J Respir Cell And Mol Biol"},{"key":"7260_CR198","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1083\/jcb.200511027","volume":"175","author":"C Tolg","year":"2006","unstructured":"Tolg C, Hamilton SR, Nakrieko K-A, Kooshesh F, Walton P, McCarthy JB, et al. Rhamm-\/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair. J Cell Biol. 2006;175:1017\u201328. https:\/\/doi.org\/10.1083\/jcb.200511027.","journal-title":"J Cell Biol"},{"key":"7260_CR199","doi-asserted-by":"publisher","first-page":"e2000493","DOI":"10.1002\/adbi.202000493","volume":"5","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Zhang S, Lee YM, Teng X, Yang Q, Toyama Y, et al. Hyaluronan-mediated motility receptor governs chromosome segregation by regulating microtubules sliding within the bridging fiber. Adv Biol. 2021;5:e2000493. https:\/\/doi.org\/10.1002\/adbi.202000493.","journal-title":"Adv Biol"},{"key":"7260_CR200","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1111\/bph.13066","volume":"172","author":"EV Gurevich","year":"2015","unstructured":"Gurevich EV, Gurevich VV. Beyond traditional pharmacology: new tools and approaches. Br J Pharmacol. 2015;172:3229\u201341. https:\/\/doi.org\/10.1111\/bph.13066.","journal-title":"Br J Pharmacol"},{"key":"7260_CR201","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.matbio.2018.01.021","volume":"78\u201379","author":"A Hauser-Kawaguchi","year":"2019","unstructured":"Hauser-Kawaguchi A, Luyt LG, Turley E. Design of peptide mimetics to block pro-inflammatory functions of HA fragments. Matrix Biol: J Int Soc For Matrix Biol. 2019;78\u201379:346\u201356. https:\/\/doi.org\/10.1016\/j.matbio.2018.01.021.","journal-title":"Matrix Biol: J Int Soc For Matrix Biol"},{"key":"7260_CR202","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.ajpath.2012.06.036","volume":"181","author":"C Tolg","year":"2012","unstructured":"Tolg C, Hamilton SR, Zalinska E, McCulloch L, Amin R, Akentieva N, et al. A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds. Am J Pathol. 2012;181:1250\u201370. https:\/\/doi.org\/10.1016\/j.ajpath.2012.06.036.","journal-title":"Am J Pathol"},{"key":"7260_CR203","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s10517-015-3041-3","volume":"159","author":"NP Akent\u2019eva","year":"2015","unstructured":"Akent\u2019eva NP, Shushanov SS, Kotel\u2019nikov AI. Effects of RHAMM\/HMMR-selective peptides on survival of breast cancer cells. Bull Of Exp Biol And Med. 2015;159:658\u201361. https:\/\/doi.org\/10.1007\/s10517-015-3041-3.","journal-title":"Bull Of Exp Biol And Med"},{"key":"7260_CR204","doi-asserted-by":"publisher","first-page":"20170030","DOI":"10.1098\/rsfs.2017.0030","volume":"7","author":"KL Zapadka","year":"2017","unstructured":"Zapadka KL, Becher FJ, Gomes Dos Santos AL, Jackson SE. Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface Focus. 2017;7:20170030. https:\/\/doi.org\/10.1098\/rsfs.2017.0030.","journal-title":"Interface Focus"},{"key":"7260_CR205","doi-asserted-by":"publisher","unstructured":"Yuan X, Qin Y, Tian Q, Liu C, Meng X, Qie B, et al. Smart delivery of poly-peptide composite for effective cancer therapy. Biomed Mater. 2022;17. https:\/\/doi.org\/10.1088\/1748-605X\/ac494c.","DOI":"10.1088\/1748-605X\/ac494c"},{"key":"7260_CR206","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1349-7006.2009.01473.x","volume":"101","author":"HS Yang","year":"2010","unstructured":"Yang HS, Zhang DM, Deng HX, Peng F, Wei YQ. Antitumor and anti-angiogenesis immunity induced by CR-SEREX-identified xenopus RHAMM. Cancer Sci. 2010;101:862\u201368. https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01473.x.","journal-title":"Cancer Sci"},{"key":"7260_CR207","doi-asserted-by":"publisher","unstructured":"Casalegno-Gardu\u00f1o R, Meier C, Schmitt A, Spitschak A, Hilgendorf I, Rohde S, et al. Immune responses to RHAMM in patients with acute myeloid leukemia after chemotherapy and allogeneic stem cell transplantation. Clin And Dev Immunol. 2012, 2012;146463. https:\/\/doi.org\/10.1155\/2012\/146463.","DOI":"10.1155\/2012\/146463"},{"key":"7260_CR208","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/leu.2010.29","volume":"24","author":"K Giannopoulos","year":"2010","unstructured":"Giannopoulos K, Dmoszynska A, Kowal M, Rolinski J, Gostick E, Price DA, et al. Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8+ T-cell responses in patients with chronic lymphocytic leukemia. Leukemia. 2010;24:798\u2013805. https:\/\/doi.org\/10.1038\/leu.2010.29.","journal-title":"Leukemia"},{"key":"7260_CR209","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3324\/haematol.2012.065581","volume":"97","author":"S Snauwaert","year":"2012","unstructured":"Snauwaert S, Vanhee S, Goetgeluk G, Verstichel G, Van Caeneghem Y, Velghe I, et al. RHAMM\/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia. Haematologica. 2012;97:1539\u201347. https:\/\/doi.org\/10.3324\/haematol.2012.065581.","journal-title":"Haematologica"},{"key":"7260_CR210","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.3390\/cells10113233","volume":"10","author":"H Zuo","year":"2021","unstructured":"Zuo H, van Lierop M-JC, Kaspers J, Bos R, Reurs A, Sarkar S, et al. Transfer of cellular content from the allogeneic cell-based cancer vaccine DCP-001 to host dendritic cells hinges on phosphatidylserine and is enhanced by CD47 blockade. Cells. 2021;10:3233. https:\/\/doi.org\/10.3390\/cells10113233.","journal-title":"Cells"},{"key":"7260_CR211","doi-asserted-by":"publisher","first-page":"7198","DOI":"10.3390\/ijms26157198","volume":"26","author":"DO Moon","year":"2025","unstructured":"Moon DO. Targeting RHAMM in cancer: crosstalk with non-coding RNAs and emerging therapeutic strategies including peptides, oligomers, antibodies, and vaccines. Int J Mol Sci. 2025;26:7198. https:\/\/doi.org\/10.3390\/ijms26157198.","journal-title":"Int J Mol Sci"},{"key":"7260_CR212","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fimmu.2015.00123","volume":"6","author":"N Nagy","year":"2015","unstructured":"Nagy N, Kuipers HF, Frymoyer AR, Ishak HD, Bollyky JB, Wight TN, et al. 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer. Front Immunol. 2015;6:123. https:\/\/doi.org\/10.3389\/fimmu.2015.00123.","journal-title":"Front Immunol"},{"key":"7260_CR213","doi-asserted-by":"publisher","first-page":"e70001","DOI":"10.1002\/pgr2.70001","volume":"2","author":"ME Erkanli","year":"2024","unstructured":"Erkanli ME, Kang TK, Kirsch T, Turley EA, Kim JR, Cowman MK. The spatial separation of basic amino acids is similar in RHAMM and hyaluronan binding peptide P15-1 despite different sequences and conformations. Proteoglycan Res. 2024;2:e70001. https:\/\/doi.org\/10.1002\/pgr2.70001.","journal-title":"Proteoglycan Res"},{"key":"7260_CR214","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.2147\/DDDT.S497126","volume":"19","author":"D Hou","year":"2025","unstructured":"Hou D, Zhou H, Tang Y, Liu Z, Su L, Guo J, et al. Dynamic visualization of computer-aided peptide design for cancer therapeutics. Drug Des, Devel And Ther. 2025;19:1043\u201365. https:\/\/doi.org\/10.2147\/DDDT.S497126.","journal-title":"Drug Des, Devel And Ther"},{"key":"7260_CR215","doi-asserted-by":"publisher","first-page":"e28385","DOI":"10.1016\/j.heliyon.2024.e28385","volume":"10","author":"FM Schipilliti","year":"2024","unstructured":"Schipilliti FM, Drittone D, Mazzuca F, La Forgia D, Guven DC, Rizzo A. Datopotamab deruxtecan: a novel antibody drug conjugate for triple-negative breast cancer. Heliyon. 2024;10:e28385. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28385.","journal-title":"Heliyon"},{"key":"7260_CR216","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","volume":"10","author":"W Xiao","year":"2025","unstructured":"Xiao W, Jiang W, Chen Z, Huang Y, Mao J, Zheng W, et al. Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. Signal Transduct And Targeted Ther. 2025;10:74. https:\/\/doi.org\/10.1038\/s41392-024-02107-5.","journal-title":"Signal Transduct And Targeted Ther"},{"key":"7260_CR217","doi-asserted-by":"publisher","first-page":"121257","DOI":"10.1016\/j.carbpol.2023.121257","volume":"320","author":"MC de Paula","year":"2023","unstructured":"de Paula MC, Carvalho SG, Silvestre ALP, Dos Santos AM, Meneguin AB, Chorilli M. The role of hyaluronic acid in the design and functionalization of nanoparticles for the treatment of colorectal cancer. Carbohydr Polym. 2023;320:121257. https:\/\/doi.org\/10.1016\/j.carbpol.2023.121257.","journal-title":"Carbohydr Polym"},{"key":"7260_CR218","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jcis.2024.06.159","volume":"674","author":"SA Martins","year":"2024","unstructured":"Martins SA, Costa RR, Brito A, Reis RL, Alves NM, Pashkuleva I, et al. Multifunctional calcium-based nanocarriers for synergistic treatment of triple-negative breast cancer. J Colloid And Interface Sci. 2024;674:500\u201312. https:\/\/doi.org\/10.1016\/j.jcis.2024.06.159.","journal-title":"J Colloid And Interface Sci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07260-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07260-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07260-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:06:15Z","timestamp":1763507175000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07260-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":218,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7260"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07260-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The review did not involve any primary data collection or human subjects research, thus eliminating the need for ethical approval and participant consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1302"}}